Gen-Probe's Q3 Revenues Rise 8 Percent

Gen-Probe's clinical diagnostics sales were up 8 percent and its blood screening products grew in the double-digits, but the top-line result fell short of analysts' consensus estimate due to softness in the healthcare market.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.